Skip to content
Lenacapavir

Lenacapavir

Regular price $1,380.00 USD
Sale price Regular price

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Bioactivity
Lenacapavir(GS-6207) is a first-in-class, long-acting HIV capsid inhibitor. Lenacapavir has anti-HIV activity with an EC50 of 100 pM in MT-4 cells and a mean EC50 of 50 pM (20-160 pM) against 23 clinical isolates of HIV-1 from different subtypes in peripheral blood mononuclear cells.
Casnumber
2189684-44-2
Formula
C39H32ClF10N7O5S2
Mw
968.28
Psmiles
CC(C)(C#CC1=NC(=C(C=C1)C2=C3[N](CC(F)(F)F)N=C(N[S](C)(=O)=O)C3=C(Cl)C=C2)C(CC4=CC(=CC(=C4)F)F)NC(=O)C[N]5N=C(C6=C5C(F)(F)C7CC67)C(F)(F)F)[S](C)(=O)=O
Purity
>98%
Solubility
DMSO ≥ 100 mg/mL
Target synonyms
GS-6207
Technical documents

Documents

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab